Skip to article
Astra

Pediatric endocrinology

Pediatric Diabetic Ketoacidosis

Pediatric diabetic ketoacidosis requires rapid confirmation of hyperglycemia, ketonemia, and acidosis; protocolized isotonic fluid resuscitation, potassium replacement, and delayed low-dose intravenous insulin; and intensive neurologic surveillance for cerebral edema while treating the precipitant and preventing recurrence.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

Clinical question: How should physicians diagnose, treat, monitor, and prevent complications of diabetic ketoacidosis in children and adolescents?

First decisions

Confirm DKA and identify patients needing higher-acuity care

Obtain treatment-critical studies without delaying resuscitation.

In a child or adolescent with diabetes symptoms, vomiting, abdominal pain, hyperventilation, dehydration, or altered consciousness, measure point-of-care glucose and blood β-hydroxybutyrate promptly. DKA requires hyperglycemia with plasma glucose >200 mg/dL, acidosis defined by pH <7.3 or bicarbonate <15 mmol/L, and β-hydroxybutyrate >3 mmol/L or urine ketones at least 2+.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE DKA can occur with normal glucose in patients already taking insulin; symptoms plus elevated ketones warrant urgent hospital assessment regardless of glucose.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

At diagnosis obtain glucose, blood ketones, pH and pCO2, bicarbonate, sodium, potassium, urea, creatinine, and body weight; document mental status, perfusion, vital signs, respiratory pattern, emesis, and clinical dehydration.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE Assess for infection or another precipitant when fever or hypothermia, hypotension, refractory acidosis, or lactic acidosis is present.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

Diagnostic and severity criteria for pediatric DKA.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
DomainCriterionImmediate implication
HyperglycemiaPlasma glucose >200 mg/dLAssess ketones and acid-base status when symptoms suggest DKA.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Ketosisβ-hydroxybutyrate >3 mmol/L or urine ketones ≥2+Treat as DKA when acidosis is also present.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
AcidosispH <7.3 or bicarbonate <15 mmol/LInitiate protocolized DKA therapy and monitoring.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Severe DKApH <7.1 or bicarbonate <5 mmol/LEscalate monitoring and obtain frequent senior review.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

First hours

Use isotonic fluids, potassium, and continuous insulin in the correct sequence

Avoid insulin boluses and avoid stopping insulin solely because glucose has normalized.

For clinically dehydrated children without shock, give 0.9% sodium chloride 10 mL/kg intravenously over 30 minutes. Reassess perfusion before considering a second 10 mL/kg bolus and discuss additional boluses with the senior pediatric clinician. For hypotensive shock with a weak, thready pulse, give 10 mL/kg 0.9% sodium chloride promptly.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

Calculate the first 48-hour fluid plan using estimated deficit plus maintenance. Assume 5% dehydration in mild-to-moderate DKA with pH ≥7.1 and 10% dehydration in severe DKA with pH <7.1; replace the deficit evenly over 48 hours. Use Holliday-Segar maintenance, capped at 75 kg, and subtract non-shock initial boluses from the estimated deficit.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

Begin a soluble insulin infusion 1-2 hours after fluid therapy begins at 0.05-0.1 units/kg/hour; do not give an IV insulin bolus. Disconnect an insulin pump when IV insulin begins. If hypokalemia is present initially, provide potassium before starting insulin; if previously using basal insulin, continuing subcutaneous basal insulin can be considered in consultation with a diabetes specialist.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

Initial treatment sequence for pediatric DKA.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
StepActionOperational detail
  1. Stabilize
Assess airway, perfusion, neurologic status, and obtain diagnostic studies.Use pediatric high-acuity care for severe DKA, age <2 years, shock, or impaired airway protection.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
  1. Restore volume
Give 0.9% sodium chloride.10 mL/kg over 30 minutes if dehydrated without shock; prompt 10 mL/kg for hypotensive shock.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
  1. Replace potassium
Add potassium to ongoing fluids when appropriate.Usually 40 mmol/L; replace before insulin if initial hypokalemia is present.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
  1. Start insulin
Begin continuous IV soluble insulin after fluids.Start 1-2 hours after fluids at 0.05-0.1 units/kg/hour; no IV bolus.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
  1. Add dextrose
Prevent hypoglycemia while continuing ketone clearance.Add 5% dextrose when glucose is <252 mg/dL; increase dextrose if glucose is <108 mg/dL with persistent ketosis.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

Potassium and sodium management

Add potassium chloride 40 mmol/L to maintenance and rehydration fluids, excluding initial boluses, unless the patient is anuric or serum potassium is above the normal range. In patients initially hyperkalemic, add potassium once potassium is <5.5 mmol/L or urine output is documented. Insulin commonly unmasks total-body potassium depletion; do not delay replacement once it is safe.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

Monitor sodium throughout therapy and calculate corrected sodium initially. Sodium should rise as glucose declines. A falling sodium concentration, or a rapid ongoing rise from free-water loss, may signal cerebral edema and requires immediate reassessment.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

Safety surveillance

Monitor neurologic status, electrolytes, glucose, and ketone clearance

Cerebral edema is a clinical emergency, not an imaging diagnosis.

Record capillary glucose, vital signs, fluid input/output, and modified Glasgow Coma Scale at least hourly. In children <2 years and those with severe DKA, assess consciousness and heart rate every 30 minutes. Use continuous ECG monitoring during IV therapy to identify hypokalemia-associated abnormalities.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE Obtain laboratory glucose, pH/pCO2, sodium, potassium, urea, and β-hydroxybutyrate at 2 hours after treatment begins and at least every 4 hours thereafter.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

A physician should perform direct reassessment at diagnosis and at least every 4 hours, more frequently for severe DKA, age <2 years, or clinical concern. At each review, reassess neurologic status, vital signs, laboratory data, ECG, and cumulative fluid balance.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

If β-hydroxybutyrate is not declining by 6-8 hours, consider increasing insulin to 0.1 units/kg/hour or higher. Do not transition from IV to subcutaneous insulin until ketosis is resolving, the patient is alert, and oral fluids are tolerated without nausea or vomiting.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

Findings that require immediate action during pediatric DKA treatment.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
FindingConcernAction
Headache, agitation, bradycardia, or hypertensionPossible cerebral edemaImmediately assess neurologic status and prepare emergent therapy.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Declining consciousness, abnormal breathing, cranial nerve findings, or unequal pupilsCerebral edemaGive mannitol or hypertonic saline immediately; seek pediatric critical care input.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Potassium <3 mmol/LHigh arrhythmia riskConsider pausing insulin and urgently intensify potassium management with critical care consultation.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Glucose <108 mg/dL with persistent ketosisInsulin must continue for ketone clearanceIncrease IV dextrose; maintain insulin at least 0.05 units/kg/hour.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Ketones not falling by 6-8 hoursInadequate insulin effect or ongoing problemReassess treatment and consider increasing insulin infusion.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

After stabilization

Prevent recurrent DKA with structured sick-day care and barrier assessment

Recurrent DKA often reflects modifiable treatment, access, or psychosocial failure points.

Before discharge after DKA in established diabetes, review the likely precipitant directly with the child or adolescent and caregivers. Insulin omission, lack of uninterrupted insulin access, intercurrent illness, and psychosocial stressors are major recurrence risks.PubMedType 1 Diabetes in Children and Adolescents - PMC - NIHnice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE The diabetes team should provide individualized written sick-day instructions covering glucose and blood ketone monitoring, insulin adjustment, fluid and food intake, and thresholds for urgent contact or evaluation; revisit this plan at least annually.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

Provide blood β-hydroxybutyrate strips and a meter, and advise ketone testing during illness or hyperglycemia. Blood ketone monitoring has practical advantages in young children and may identify metabolic deterioration earlier than urine testing.PubMedType 1 Diabetes in Children and Adolescents - PMC - NIH

Assess recurrent DKA for nonadherence sensitively and evaluate psychosocial well-being. Pediatric diabetes care should include access to multidisciplinary education, nutrition, mental health, and 24-hour clinical advice, with ongoing family involvement that is developmentally appropriate.PubMed14. Children and Adolescents: Standards of Care in Diabetes ...PubMedType 1 Diabetes in Children and Adolescents - PMC - NIHnice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

Discharge-critical elements after pediatric DKA.PubMedType 1 Diabetes in Children and Adolescents - PMC - NIHnice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
DomainRequired actionClinical purpose
Sick-day planProvide oral and written guidance on glucose and β-hydroxybutyrate monitoring, insulin adjustment, hydration, and escalation criteria.Reduce delayed recognition of ketosis and recurrent DKA.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Ketone accessSupply a blood ketone meter and unexpired strips.Enable illness and hyperglycemia assessment outside the hospital.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Insulin accessVerify access to uninterrupted insulin and delivery supplies.Insulin omission or inability to obtain insulin increases DKA risk.PubMedType 1 Diabetes in Children and Adolescents - PMC - NIH
Psychosocial assessmentAddress recurrent DKA, adherence barriers, distress, family conflict, and social needs.Psychosocial factors can impair diabetes self-management.PubMed14. Children and Adolescents: Standards of Care in Diabetes ...PubMedType 1 Diabetes in Children and Adolescents - PMC - NIH

Common questions

Can pediatric DKA occur with a normal glucose level?

Yes. Children and adolescents already receiving insulin may develop DKA with normal blood glucose. Nausea, vomiting, abdominal pain, hyperventilation, dehydration, or altered consciousness should trigger blood ketone measurement and urgent evaluation.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

Should an IV insulin bolus be given in pediatric DKA?

No. The cited pediatric DKA guideline recommends starting a continuous soluble insulin infusion 1-2 hours after IV fluids at 0.05-0.1 units/kg/hour and specifically advises against IV insulin boluses.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

When should dextrose be added during pediatric DKA treatment?

Change to 0.9% sodium chloride with 5% dextrose when plasma glucose falls below 14 mmol/L (252 mg/dL). If glucose falls below 6 mmol/L (108 mg/dL) with persistent ketosis, increase IV glucose while continuing insulin.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

What findings should trigger empiric treatment for cerebral edema?

Treat immediately when DKA is accompanied by declining consciousness, abnormal breathing, oculomotor palsy, or pupillary inequality or dilation. Headache, agitation, unexpected bradycardia, and hypertension are early warning signs requiring urgent assessment.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

When can intravenous insulin be stopped?

Do not stop IV insulin until ketosis is resolving, the patient is alert, and oral fluids are tolerated without nausea or vomiting. Give subcutaneous insulin at least 30 minutes before discontinuing IV insulin; restart a pump at least 60 minutes before stopping IV insulin.nice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE

References

  1. highlights of prescribing informationdailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  2. These highlights do not include all the information needed to use LEVEMIR® safely and effectively.See full prescribing information for LEVEMIR. LEVEMIR® (insulin detemir) injection, for subcutaneous useInitial U.S. Approval: 2005dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  3. These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  4. rivaroxaban tablet, film coated XARELTO - DailyMeddailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  5. Current Management of Type 1 Diabetes in Children: Guideline-based Expert Opinions and Recommendationspmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  6. Diabetes (type 1 and type 2) in children and young people: ...www.nice.org.uk · www.nice.org.uk
  7. Management of Newly Diagnosed Type 2 Diabetes ...pediatrics.aappublications.org · pediatrics.aappublications.org
  8. 14. Children and Adolescents: Standards of Care in Diabetes ...pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  9. Type 1 Diabetes Mellitus | Pediatrics In Reviewpedsinreview.aappublications.org · pedsinreview.aappublications.org
  10. Type 1 Diabetes in Childrenwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  11. Type 1 Diabetes in Children and Adolescents - PMC - NIHpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  12. Diabetes in Children and Adolescents - Diabetes in America - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  13. Pediatric Type 2 Diabetes - StatPearls - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  14. Pediatric Clinical Practice Guidelines & Policiesreader.aappublications.org · reader.aappublications.org
  15. Standards of Medical Care in Diabetes—2021 Abridged for ...pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  16. Management of Type 2 Diabetes Mellitus in Children and ...pediatrics.aappublications.org · pediatrics.aappublications.org
  17. 14. Children and Adolescents: Standards of Medical Care in ...diabetesjournals.org · diabetesjournals.org
  18. Screening for Prediabetes and Type 2 Diabetes Mellitus in ...www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  19. Prevention and Treatment of Type 2 Diabetes Mellitus in ...pediatrics.aappublications.org · pediatrics.aappublications.org
  20. Diabetes Care - American Diabetes Associationdiabetesjournals.org · diabetesjournals.org
  21. Recommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICEwww.nice.org.uk · www.nice.org.uk
  22. Type 1 Diabetes Screening in Pediatricspublications.aap.org · publications.aap.org
  23. Diabetes Clinical Practice Guideline Quick Reference Toolspublications.aap.org · publications.aap.org
  24. Management of Type 1 Diabetes in Children in the ...publications.aap.org · publications.aap.org